Search Results
You are looking at 1-10 of 34
![<bold>Figure 2.</bold>](/view/journals/anpr/60/2/inline-i0003-3006-60-2-72-f02.png)
Platelet aggregation and actions of antiplatelet drugs. 1,3 Resting platelets have specific receptors for ligands that trigger activation: epinephrine, thrombin, serotonin, collagen, adenosine diphosphate (ADP), and thromboxane A2 (TXA2). When activated, intracellular calcium levels elevate and the platelet expresses glycoprotein (GP) IIb/IIIa receptors that bind to strands of fibrinogen. This results in platelet aggregation. The various antiplatelet drugs inhibit aggregation by targeting specific aspects of this process.
![Figure 2](/view/journals/anpr/55/2/inline-i0003-3006-55-2-49-f02.gif)
Resting platelets are activated by a variety of chemical mediators, each of which can be targeted by antiplatelet drugs summarized in Table 2. Activated platelets aggregate by binding to strands of fibrinogen, which can be prevented by drugs that block the activated receptors.
![Figure 1](/view/journals/anpr/55/2/inline-i0003-3006-55-2-49-f01.gif)
Summary of thrombogenesis and thrombolysis. A thrombus consists of 2 principal components: an aggregate of platelets and a fibrin mesh. Platelet activity consists of adherence to vessel walls (adhesion) and to one another (aggregation). The fibrin mesh is synthesized during a complex cascade of enzymatic reactions leading to the formation of fibrin strands (coagulation). The body also has a natural thrombolytic system, essentially comprised of plasmin, an enzyme that cleaves fibrin strands. Antithrombotic drugs are classified according to action on each of these processes: antiplatelet drugs, anticoagulants, and thrombolytics (fibrinolytics).
![<bold>Figure 1.</bold>](/view/journals/anpr/60/2/inline-i0003-3006-60-2-72-f01.png)
Thrombogenesis. A thrombus consists of 2 principal components: an aggregate of platelets and a fibrin mesh. Platelet activity consists of adherence to vessel walls (adhesion) and to one another (aggregation). The fibrin mesh is synthesized during a complex cascade of enzymatic reactions leading to the formation fibrin strands (coagulation). The body also has a natural thrombolytic system, essentially comprised of plasmin, an enzyme that cleaves fibrin strands. Antithrombotic drugs are classified according to action on each of these processes: antiplatelet drugs, anticoagulants, and thrombolytics (fibrinolytics).
![Figure 1.](/view/journals/anpr/69/3/inline-i1878-7177-69-3-40-f01.png)
Classic coagulation cascade model featuring the extrinsic, intrinsic, and common coagulation pathways.
![Figure 2.](/view/journals/anpr/69/3/inline-i1878-7177-69-3-40-f02.png)
Contemporary coagulation model demonstrating the 3 phases: activation (A-C), amplification (D-F), and clot propagation (G). 3